Drug Eluting Balloon Market is expected to show growth from 2024 to 2030, reported by Maximize Market Research

Global Drug Eluting Balloon Market is expected to reach US$ 2.61 Bn. at a CAGR of 5.1 % during the forecast period 2030.

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

DEB are angioplasty balloons coated with anti-proliferative drug, released during inflation into vessel wall at nominal pressures with minimal inflation time. Important in healthcare for delivering medication and preventing neointimal hyperplasia. The increasing prevalence of coronary artery diseases worldwide is driving the global market growth. Manufacturers are focusing on acquisition strategies to create innovative products, expanding their portfolios. Major players like Medtronic, Inc. and Boston Scientific Corporation, along with ongoing R&D for drug-eluting balloons, are further boosting market growth.

However, adverse effects like lumen enlargement and coronary artery lesions may hinder market growth in the future. Growth in drug-eluting balloon catheters market is fueled by rising cardiovascular disease prevalence, especially coronary artery and peripheral artery diseases, driving demand for better treatment options to reduce restenosis risks and enhance patient outcomes. The major key players are the Medtronic, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical Incorporated, Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, and Terumo Corporation. North America is projected to be the top revenue generator in the global market due to rising rates of cardiovascular diseases and obesity. Sedentary lifestyles, poor diet, and stress are contributing factors leading to chronic conditions like diabetes and obesity, increasing the occurrence of cardiovascular diseases such as coronary artery disease and strokes.

𝐍𝐞𝐞𝐝 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 + 𝐆𝐫𝐚𝐩𝐡𝐬 𝐇𝐞𝐫𝐞:https://www.maximizemarketresearch.com/request-sample/40237/

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭:

May 2022: MedAlliance's SELUTION SLR drug-eluting Ballon received FDA investigational device exemption approval. The SELUTION SLR provides a controlled, sustained drug release for below-the-knee indications in peripheral artery disease.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)

𝐘𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐈𝐬 𝐉𝐮𝐬𝐭 𝐚 𝐂𝐥𝐢𝐜𝐤 𝐀𝐰𝐚 :https://www.maximizemarketresearch.com/request-sample/40237/

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐓𝐲𝐩𝐞

Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others

𝐛𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

Paccocath
FreePac
TransPax
EnduraCoat
Others

𝐛𝐲 𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Hospitals & Ambulatory Surgery Centers
CATH Laboratories
Others

𝐂𝐮𝐫𝐢𝐨𝐮𝐬 𝐭𝐨 𝐩𝐞𝐞𝐤 𝐢𝐧𝐬𝐢𝐝𝐞? 𝐆𝐫𝐚𝐛 𝐲𝐨𝐮𝐫 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐰:https://www.maximizemarketresearch.com/request-sample/40237/

𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬

Medtronic, Inc.
Becton, Dickinson and Company
Boston Scientific Corporation
Cook Medical Incorporated
Braun Melsungen AG
Koninklijke Philips N.V.
Opto Circuits (India) Limited
Terumo Corporation
Surmodics, Inc.
Biotronik, Inc.
Concept Medical Inc.
BIOTRONIK SE & Co. KG
Innvolution Healthcare Pvt. Ltd.
Medtronic plc
Eurocor GmbH
R. Bard
Aachen Resonance GmbH

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞 𝐀𝐛𝐨𝐮𝐭 𝐓𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.maximizemarketresearch.com/market-report/global-drug-eluting-balloon-market/40237/

𝐊𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐃𝐫𝐮𝐠 𝐄𝐥𝐮𝐭𝐢𝐧𝐠 𝐁𝐚𝐥𝐥𝐨𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

Which region has the largest share in Global Drug Eluting Balloon Market?
What is the growth rate of Global Drug Eluting Balloon Market?
What is scope of the Global Drug Eluting Balloon market report?
Who are the key players in Global Drug Eluting Balloon market?
What is the study period of this market?

𝐊𝐞𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬:

Past Drug Eluting Balloon Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Drug Eluting Balloon Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by
Region
Market Segmentation - A detailed analysis by segment with their sub-segments and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations

𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐡𝐚𝐬 𝐚𝐥𝐬𝐨 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐨𝐧

Pediatric Neuroblastoma Treatment Market is expected to reach US$ 4.26 Bn. at a CAGR of 10.2% during the forecast period 2030.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/pediatric-neuroblastoma-treatment-market/36953/

Biologics Market size was valued at US$ 392.95 Bn. in 2023 and the total revenue is expected to grow at 9.1 % through 2024 to 2030, reaching nearly US$ 722.96 Bn.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/biologics-market/37255/

Global Special Engineering Vehicle Market is expected to grow at a CAGR of 5% during the forecast period. Special Engineering Vehicle Market is expected to reach US$ 682.99 Mn. by 2029.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/special-engineering-vehicle-market/38906/

Amino Acid Metabolism Disorders Treatment Market is expected to reach US$ 674.85 Mn. at a CAGR of 5.3 during the forecast period 2029.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/amino-acid-metabolism-disorders-treatment/39775/

Global Healthcare OEM Market size is expected to reach US$ 499.6 Bn. by year 2029 at a CAGR of 16.2% during the forecast period.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/global-healthcare-oem-market/54464/

Autologous Cell Therapy Market size was valued at USD 8.09 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 21. 7% through 2024 to 2030, reaching nearly USD 31.73 Bn.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/autologous-cell-therapy-market/171125/

Automatic Pill Dispenser Market size was valued at US$ 2.63 Bn. in 2023 and the total revenue is expected to grow at CAGR 9.7 % through 2024 to 2030, reaching nearly US$ 5.03 Bn.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/automatic-pill-dispenser-market/123296/

Global Bispecific Antibodies Market size was valued at USD 0.58 billion in 2023 and expected to reach USD 0.95 billion by 2030, at CAGR of 7.39%.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/bispecific-antibodies-market/217462/

Global Blood Glucose Monitoring System Market size was valued at USD 13.71 Bn in 2023 and is expected to reach USD 24.11 Bn by 2030, at a CAGR of 8.4%.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/blood-glucose-monitoring-system-market/1433/

Asia Pacific Blood Glucose Monitoring System Market size was valued at US$ 3.3 Bn. in 2021 and the total Asia Pacific Blood Glucose Monitoring System Market revenue is expected to grow at 9.5 % from 2021 to 2029, reaching nearly US$ 6.8 Bn.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/blood-glucose-monitoring-system-market-asia-pacific/1655/

Global Bone Screw System Market size was valued at USD 858.51 Mn in 2023 and the total revenue is expected to grow at 6.7% through 2024 to 2030, reaching nearly USD 1351.75 Mn.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/bone-screw-system-market/121454/

The Bowel Management Systems Market was valued at US$ 3.18 Bn. in 2023. Global Bowel Management Systems Market size is estimated to grow at a CAGR of 4.5% over the forecast period.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/bowel-management-systems-market/137367/

The Global Breast Cancer Liquid Biopsy Market is projected to grow from USD 470.26 Mn. in 2023 to USD 1671.22 Mn. by 2030, at a CAGR of 19.86% during the forecast period.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/breast-cancer-liquid-biopsy-market/12622/

The BRICS Diabetes Drugs Market value is projected to reach USD 97.56 Bn. at the end of the forecast period and it is expected to grow at the CAGR of 12.2%.

𝐆𝐞𝐭 𝐈𝐧𝐟𝐨:https://www.maximizemarketresearch.com/market-report/brics-diabetes-drugs-market/356/

𝐌𝐀𝐗𝐈𝐌𝐈𝐙𝐄 𝐌𝐀𝐑𝐊𝐄𝐓 𝐑𝐄𝐒𝐄𝐀𝐑𝐂𝐇 𝐏𝐕𝐓. 𝐋𝐓𝐃.

⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Maximize Market Research is a global Market research and consulting company that provides businesses with insights to foster their growth and competitive advantage. The company specializes in delivering actionable and data-driven research reports tailored to help organizations make informed decisions. With a team of experienced analysts and consultants, Maximize Market Research offers expertise across multiple industries, including healthcare, technology, manufacturing, consumer goods, and more. Their services cover Market sizing, forecasting, competitive analysis, and customer insights, helping clients to address their strategic needs and identify emerging trends. The company emphasizes client success, offering detailed analysis and recommendations that support business transformation and operational excellence. Maximize Market Research also provides custom research services, allowing businesses to get solutions specific to their Market challenges. With a strong global presence, the company serves clients from various sectors, ensuring they stay ahead in a rapidly evolving Market landscape.

This release was published on openPR.